Fusion event
HBV-chr9 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
GCTCCTCTGCCGATCCATACTGCGGAACTCCTAGCCGCTTGTTTTGCTCGCAGCAGGTCTGGAGCAAACATTATCGGGACTGATAACTCTGTTGTCCTAT| |CCCGCAAATATACATCGTTTCCATGGCTGCTAGGCTGTGCTGCCAACTGGATCCTGCGCGGGACGTCCTTTGTTTACGTCCCGTCGGCGCTGAATCCTGC
End
66849881/40896853 (Hg38)
Nearest miRNA
hsa-mir-101-2/Upstream/4003322; hsa-let-7a-1/Downstream/32157;
Upstream sequence
ACTGGATTTTACATAAAGCTTCAGGGCTGACCAAGGAATTAGATGCAGTTCAGAGATGTGAagcatgggtagtgcagcaacatggagcactgaaatcaaa
Downstream sequence
acaaatggacatctggagcactttttgtcctatggaagaaaatgaagtatcttcacataaaatctagacagaaacaatctgagaaacttctctgtgatgt
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.